ArticleFrontiers in oncology2026

Preclinical identification of an oxadiazole-pyrazole lead targeting prostate cancer through integrated mechanistic evaluation.

Vanktesh Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.